David R. Holmes, MD, FACC, Michael J

Slides:



Advertisements
Similar presentations
Volume 1, Issue 2, Pages (April 2017)
Advertisements

Intracardiac Echocardiography: A New Guiding Tool for Transcatheter Aortic Valve Replacement  Thomas Bartel, MD, Nikolaos Bonaros, MD, Ludwig Müller,
David R. Holmes, MD, Michael J
Of mice and men and surgical transcatheter aortic valve insertion
Two cases of aneurysm of the anterior mitral valve leaflet associated with transcatheter aortic valve endocarditis: A mere coincidence?  Nicolo Piazza,
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis 
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
Paul J. Chai, MD, Isaac George, MD, Tamim M. Nazif, MD, FACC, David M
Intracardiac Echocardiography: A New Guiding Tool for Transcatheter Aortic Valve Replacement  Thomas Bartel, MD, Nikolaos Bonaros, MD, Ludwig Müller,
First successful transapical aortic valve implantation after aortic allograft replacement  Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou,
Acute aortic dissection with coronary ostium involvement and aortic valve regurgitation: Three-dimensional visualization with multislice computed tomography 
Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.
Real-Time Magnetic Resonance–Guided Aortic Valve Replacement Using Engager Valve  Bogdan A. Kindzelski, BS, Ming Li, PhD, Dumitru Mazilu, PhD, Timothy.
Transcatheter Aortic Valve Replacement
Transcatheter Valve Implantation in Mitral Annular Calcification During Open Surgery: Extended Collar Technique  Michael Ghosh-Dastidar, MBBS, FRCSCTh,
Arman Kilic, MD, Mary A. Siki, BS, Wilson Y. Szeto, MD, Joseph E
David R. Holmes, MD, FACC, Michael J
Transatlantic editorial on transcatheter aortic valve replacement
Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.
Transapical transcatheter aortic valve implantation and off-pump left internal thoracic artery–left anterior descending anastomosis: Back to the future? 
Transapical aortic valve implantation in patients with severely depressed left ventricular function  Axel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih.
Chun Wang, MD, Zongyi Xiu, MD, Tianxiang Gu, MD 
An alternate approach to valve replacement in patients with mitral stenosis and severely calcified annulus  Sameh M. Said, MD, Hartzell V. Schaff, MD 
Transcatheter aortic valve implantation combined with conventional heart surgery: Hybrid approach for complex cardiac pathologic features  Miralem Pasic,
Midterm results of transapical aortic valve replacement via real-time magnetic resonance imaging guidance  Keith A. Horvath, MD, Dumitru Mazilu, PhD,
Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.
Left atrial appendage aneurysm causes severe mitral regurgitation and heart failure: Report of a successfully treated case  Mitsuhiro Kawata, MD, PhD,
Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: First case report  Thomas Modine, MD, Gilles Lemesle, MD,
Patrick T. O'Gara, MD, MACC, FAHA, Thoralf M. Sundt, MD, Michael A
Marek Polomsky, MD, Konstantinos P. Koulogiannis, MD, Robert M
David R. Holmes, MD, Michael J
Jeffrey E. Keenan, MD, John P. Vavalle, MD, Asvin M
Successful repair of a variant of mitral arcade
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement  Thomas.
Maher N. Abadeer, MD, Peter C. Kouretas, MD, PhD, Ronald K
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Prognostic significance of mild aortic regurgitation in predicting mortality after transcatheter aortic valve replacement  Brandon M. Jones, MD, E. Murat.
Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis  Adil H. Al Kindi,
Use of the hybrid operating room for aortic valve replacement in a patient with anomalous left circumflex artery  Ramanan Umakanthan, MD, Zachary E. Brewer,
Reoperative innominate arterial, ascending aortic, and root replacement for extensive fungal endocarditis  Bradley G. Leshnower, MD, Thomas G. Gleason,
Michele Gallo, MD, Gino Gerosa, MD 
Monobloc aorto-mitral homograft as a treatment of complex cases of endocarditis  Jean-François Obadia, MD, PhDa, Olivier Raisky, MDa, Laurent Sebbag, MDa,
Alternative access for balloon-expandable transcatheter aortic valve replacement: Comparison of the transaortic approach using right anterior thoracotomy.
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Anna Marciniak, PhD, Georgios T
Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality  Hersh S. Maniar, MD, Brian R. Lindman, MD,
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Compassionate aortic valve implantation for severe aortic regurgitation  Gregory Ducrocq, MD, Dominique Himbert, MD, Ulrik Hvass, MD, Alec Vahanian, MD 
The trans-subclavian retrograde approach for transcatheter aortic valve replacement: Single-center experience  Giuseppe Bruschi, MD, Pasquale Fratto,
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
A fate worse than death  Jennifer S. Lawton, MD 
Cardiac surgery in patients with a porcelain aorta
Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend  G. Michael Deeb, MD, John Carroll, MD  The Journal.
The harder one looks, the more one finds
Concomitant replacement of the ascending aorta is free—for some
Preserving the V-engine shape of the left ventricle with Melody mitral valve replacement in small children  Patrick O. Myers, MD  The Journal of Thoracic.
Congenital supravalvar mitral ring: An underestimated anomaly
Basar Sareyyupoglu, MD, Hartzell V. Schaff, MD, Rakesh M
The future of cardiac surgery training: A survival guide
Commentary: When a choice is not an echo
Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: Impact of aortic cusp calcification on postoperative aortic regurgitation 
Novel treatment for critical aortic stenosis with severe aortic root calcification and coronary disease: Combined left internal thoracic artery graft.
Aneurysmal right coronary with fistula to the coronary sinus combined with severe stenosis of the left anterior descending artery: A snake on the heart 
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Transcatheter aortic and mitral valve implantation in bioprosthetic valves: When one correction is not enough  Adanna C. Akujuo, MD, FACS, Sophia L. Dellis,
Implantation of a Sapien XT aortic bioprosthesis with the NovaFlex catheter through a subclavian access  Bertrand Marcheix, MD, PhD, Etienne Grunenwald,
Giant right coronary artery aneurysm with a huge intramural thrombus
Three mechanisms of early failure of transcatheter aortic valves: Valve thrombosis, cusp rupture, and accelerated calcification  Matthew R. Summers, MD,
Left atrial to left ventricle bypass for mitral valve stenosis
Feasibility of transapical aortic valve implantation guided by intracardiac ultrasound without angiography  Enrico Ferrari, MD, Carlo Marcucci, MD, Stefano.
Presentation transcript:

2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement  David R. Holmes, MD, FACC, Michael J. Mack, MD, FACC, Sanjay Kaul, MBBS, FACC, Arvind Agnihotri, MD, Karen P. Alexander, MD, FACC, Steven R. Bailey, MD, FACC, FSCAI, John H. Calhoon, MD, Blase A. Carabello, MD, FACC, Milind Y. Desai, MBBS, FACC, Fred H. Edwards, MD, FACC, Gary S. Francis, MD, FACC, Timothy J. Gardner, MD, FACC, A. Pieter Kappetein, MD, PhD, Jane A. Linderbaum, MS, CNP, AACC, Chirojit Mukherjee, MD, Debabrata Mukherjee, MD, FACC, Catherine M. Otto, MD, FACC, Carlos E. Ruiz, MD, PhD, FACC, FSCAI, Ralph L. Sacco, MD, MS, FAHA, Donnette Smith, James D. Thomas, MD, FACC  The Journal of Thoracic and Cardiovascular Surgery  Volume 144, Issue 3, Pages e29-e84 (September 2012) DOI: 10.1016/j.jtcvs.2012.03.001 Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 1 Sapien valve. Source: Edwards Lifesciences. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 2 CoreValve. The Medtronic CoreValve System is currently limited to investigational use in the United States. Source: Medtronic, Inc. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 3 PARTNER trial design. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 4 Benefit/risk balance in the PARTNER trial. Data are shown for every 1000 patients treated with TAVR instead of standard treatment in Cohort B (above) or standard AVR in Cohort A (below). The excesses listed are not mutually exclusive, because some patients had more than 1 event. Only data with statistically significant differences at 1 year of follow-up are shown except for deaths* (P = .44) and atrial fibrillation† (P = .07) in Cohort A. AR, Aortic valvular regurgitation; AVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 5 Reconstructed multidetector computed tomographic images of the abdominal aorta and its pelvic branches demonstrating tortuosity and extensive calcific atherosclerosis. The extent and degree of peripheral arterial disease is essential in determining the feasibility and safety of transfemoral approaches. In some patients with extensive disease, alternative approaches such as direct aortic, subclavian, or transapical procedures should be considered. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 6 Midesophageal long-axis TEE view showing the proper positioning of a sapien valve (black line*) across the aortic annulus prior to balloon deployment. Note that approximately half the valve is above and below the annulus. Note also the difficulty of imaging due to shadowing from the prosthesis and annular and mitral valve calcification, as well as a prominent reverberation artifact, emphasizing the need for thorough training prior to providing procedural guidance. LA, Left atrium. ∗Visible as black line. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 7 Mixed AR. Central and paravalvular AR following TAVR deployment in a biplane long- and short-axis TEE view. A1 and A2 are trivial paravalvular leaks, whereas B is a trivial central regurgitation, all of which are negligible. C is a more severe paravalvular leak, which was ameliorated by a second valve inflation. Ao, Aorta; AR, aortic regurgitation; LA, left atrium; LV, left ventricle. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions

Figure 8 Severe AR. Long-axis TEE view showing severe AR following TAVR deployment (A), confirmed by flow reversal in the descending aorta (B). Short axis imaging (C and D) demonstrates that this is due to failure of the leaflet in the left coronary position (arrow) to close in diastole, ultimately treated by deploying a second valve inside this one. Ao, Aorta; AR, aortic regurgitation; LA, left atrium; LV, left ventricle. The Journal of Thoracic and Cardiovascular Surgery 2012 144, e29-e84DOI: (10.1016/j.jtcvs.2012.03.001) Copyright © 2012 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Terms and Conditions